Reporting cases of thrombosis with thrombocytopenia syndrome (TTS) after receipt of J&J vaccine

On April 21, 2021, the California Department of Public Health (CDPH) issued the following Health Advisory: Pause in administration of the Johnson & Johnson COVID-19 vaccine; Reporting of cases of thrombosis with thrombocytopenia syndrome (TTS) after receipt of Johnson & Johnson vaccine.

All cases of thrombosis with thrombocytopenia syndrome (TTS) following receipt of J &J COVID-19 vaccine, as well as other adverse events following vaccination, should be reported to the CDC/FDA Vaccine Adverse Event Reporting System (VAERS).


Terms of Use  |  Privacy